Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
"Dipeptidyl-Peptidases and Tripeptidyl-Peptidases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subclass of exopeptidases that includes enzymes which cleave either two or three AMINO ACIDS from the end of a peptide chain.
Below are MeSH descriptors whose meaning is more general than "Dipeptidyl-Peptidases and Tripeptidyl-Peptidases".
Below are MeSH descriptors whose meaning is more specific than "Dipeptidyl-Peptidases and Tripeptidyl-Peptidases".
This graph shows the total number of publications written about "Dipeptidyl-Peptidases and Tripeptidyl-Peptidases" by people in Harvard Catalyst Profiles by year, and whether "Dipeptidyl-Peptidases and Tripeptidyl-Peptidases" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1992 | 1 | 0 | 1 |
| 1993 | 1 | 1 | 2 |
| 1994 | 1 | 0 | 1 |
| 1996 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2002 | 0 | 2 | 2 |
| 2004 | 1 | 1 | 2 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 3 | 3 |
| 2008 | 0 | 1 | 1 |
| 2010 | 2 | 1 | 3 |
| 2011 | 0 | 1 | 1 |
| 2012 | 3 | 1 | 4 |
| 2013 | 3 | 3 | 6 |
| 2014 | 2 | 2 | 4 |
| 2015 | 3 | 0 | 3 |
| 2016 | 2 | 0 | 2 |
| 2017 | 1 | 1 | 2 |
| 2018 | 2 | 0 | 2 |
| 2019 | 4 | 2 | 6 |
| 2021 | 1 | 1 | 2 |
Below are the most recent publications written about "Dipeptidyl-Peptidases and Tripeptidyl-Peptidases" by people in Profiles.
-
Effects of dipeptidyl peptidase-4 inhibitors and sulphonylureas on cognitive and physical function in nursing home residents. Diabetes Obes Metab. 2022 02; 24(2):247-256.
-
Dipeptidyl peptidase 9 sets a threshold for CARD8 inflammasome formation by sequestering its active C-terminal fragment. Immunity. 2021 07 13; 54(7):1392-1404.e10.
-
DPP9 sequesters the C terminus of NLRP1 to repress inflammasome activation. Nature. 2021 04; 592(7856):778-783.
-
Genetic mechanisms of critical illness in COVID-19. Nature. 2021 03; 591(7848):92-98.
-
Identification of Plasmodium dipeptidyl aminopeptidase allosteric inhibitors by high throughput screening. PLoS One. 2019; 14(12):e0226270.
-
A High-Content Screen Identifies TPP1 and Aurora B as Regulators of Axonal Mitochondrial Transport. Cell Rep. 2019 Sep 17; 28(12):3224-3237.e5.
-
Characterization of P. falciparum dipeptidyl aminopeptidase 3 specificity identifies differences in amino acid preferences between peptide-based substrates and covalent inhibitors. FEBS J. 2019 10; 286(20):3998-4023.
-
Neurological autoimmune disorders with prominent gastrointestinal manifestations: A review of presentation, evaluation, and treatment. Neurogastroenterol Motil. 2019 10; 31(10):e13611.
-
Omega-3 Fatty Acids and Genome-Wide Interaction Analyses Reveal DPP10-Pulmonary Function Association. Am J Respir Crit Care Med. 2019 03 01; 199(5):631-642.
-
Comment on "Oral diabetes medications other than dipeptidyl peptidase-4 inhibitors are not associated with bullous pemphigoid: A Finnish nationwide case-control study" and a case report of glucagon-like peptide-1 receptor agonist-induced bullous pemphigoid. J Am Acad Dermatol. 2019 06; 80(6):e189-e190.